Month: May 2021

Net sales increased 13.7% Gross margin expanded 30 basis points 12.9% operating margin, 13.1% on an adjusted basis, up 230 basis points Adjusted EBITDA increased 31.1%, adjusted EBITDA margin up 210 basis points $1.80 net income per diluted share, $2.02 on an adjusted basisDAYTONA BEACH, Fla., May 06, 2021 (GLOBE NEWSWIRE) —  TopBuild Corp. (NYSE:BLD), a leading installer and distributor of insulation and building material products today reported results for the first quarter ended March 31, 2021. Robert Buck, President and Chief Executive Officer, stated, “TopBuild reported another solid quarter with sales benefitting from the strong growth in both our residential and commercial businesses. Adjusted operating margins expanded at both TruTeam and Service Partners, despite the impact of severe weather in February, most notably...

ANNOUNCES FDA ACCEPTED FOR FILING REATA’S NDA OF BARDOXOLONE FOR THE TREATMENT OF PATIENTS WITH CKD CAUSED BY ALPORT SYNDROME IF APPROVED, BARDOXOLONE MAY BECOME THE FIRST APPROVED THERAPY FOR ALPORT SYNDROME, A LIFE-THREATENING DISEASE THAT AFFECTS 30,000 – 60,000 PATIENTS IN THE U.S. REAFFIRMS ANTICIPATED COMPLETION OF ENROLLMENT BY END OF 2021 IN PHASE 3 FALCON TRIAL FOR ADPKD FDA GRANTED TYPE C MEETING TO DISCUSS FA DEVELOPMENT PROGRAM IN 2Q 2021 CONFIRMS CASH RUNWAY THROUGH MID-2024 CONFERENCE CALL WITH MANAGEMENT ON MAY 6, 2021 AT 8:30 A.M. ET PLANO, Texas, May 06, 2021 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a clinical-stage biopharmaceutical company, today announced financial results for the quarter ended March 31, 2021, and provided an update on the...

Net Revenues: $24.5 million, a 14% increase Net Income: $0.7 million, a $1.1 million increase, Adjusted EBITDA: $6.2 million, a 51% increase, and Adjusted EBITDA margin of 25.2%, a 6.3% increase Company Reaffirms Full Year 2021 Guidance ROCHESTER HILLS, Michigan, May 06, 2021 (GLOBE NEWSWIRE) — InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the first quarter ended March 31, 2021. 2021 First Quarter Highlights:Net revenues were $24.5 million, an increase of 14% vs. prior year. Gross profit was $14.6 million, an increase of 15% vs. prior year. Gross margin was 59.6%, an improvement of 0.8% vs. prior year. Net income...

PARIS, May 06, 2021 (GLOBE NEWSWIRE) — HSBC (contact: Syndicate desk, telephone: +44 207 992 8066) hereby gives notice that no stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.Issuer: ORPEA SAGuarantor (if any): naAggregate nominal amount: EUR 500,000,000                  Description: 2% due 1st April 2028Offer price: 99.195Stabilising Managers: HSBC Bank plc                       This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction  This information is provided by RNS, the news service of the London Stock...

TORONTO, May 06, 2021 (GLOBE NEWSWIRE) — Kirkland Lake Gold Ltd. (“Kirkland Lake Gold” or the “Company”) (TSX:KL) (NYSE:KL) (ASX:KLA) today announced the Company’s financial and operating results for the first quarter of 2021 (“Q1 2021”). The results for the quarter exceeded target levels in a number of key areas, including production and all-in sustaining costs (“AISC”) per ounce sold(1), which reflected stronger than expected production and sales at Fosterville and Detour Lake, as well as lower than planned sustaining capital expenditures. The Company’s full financial statements and management discussion & analysis are available on SEDAR at www.sedar.com and on the Company’s website at www.kl.gold. All dollar amounts are in U.S. dollars, unless otherwise noted.Q1 2021 PRODUCTION BEATS GUIDANCEProduction of 302,847 exceeded...

Raised $925 million of corporate capital through the issuance of the 2031 “Green Bond” Senior Notes Closed the acquisition of the 264 MW Mt. Storm wind project Executed a multi-year, 100 MW Resource Adequacy agreement at Marsh Landing Raising pro forma CAFD outlook Increasing the quarterly dividend by 1.5% to $0.329 per share in the second quarter of 2021; On track to achieve the upper end of 5-8% annual growth target by year endPRINCETON, N.J., May 06, 2021 (GLOBE NEWSWIRE) — Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) today reported first quarter 2021 financial results, including a Net Loss of $76 million, Adjusted EBITDA of $198 million, Cash from Operating Activities of $47 million, and Cash Available for Distribution (CAFD) of $(15) million. “Clearway continues to execute on its business objectives through...

H1 2020/21Interim financial results, H1 2020/21(1 October 2020 – 31 March 2021) Organic growth guidance maintained at 7-8% and EBIT margin guidance before special items raised from 31-32% to 32-33%.Coloplast delivered 2% organic growth in Q2. Reported revenue in DKK was down by 1% to DKK 4,753 million. Year to date organic growth was 4% and reported revenue in DKK was flat at DKK 9,491 million due to significant FX headwinds. Organic growth rates by business area year to date: Ostomy Care 5%, Continence Care 3%, Interventional Urology 4% and Wound & Skin Care 1%. The Chronic Care business in Q2 was negatively impacted by around DKK 150 million in stock building in the comparison period and lower growth in new patients in Europe due to COVID-19, in particular in the UK. Ostomy Care delivered 4% organic growth in Q2 lifted by...

Revenue increased 17.5% to $1,027 million. Organic revenue increased 12.1% GAAP EPS increased to $0.53 vs loss of ($0.63) in 2020 Non-GAAP EPS increased 67.4% to $0.72 vs $0.43 in 2020 GAAP operating income increased to $154 million vs loss of ($125) million in 2020 Non-GAAP operating income increased 67.2% to $219 million vs $131 million in 2020 Operating cash flows increased to $49 million vs loss of ($10) million in 2020 Raises FY21 Non-GAAP EPS outlook to $2.75 to $2.90 from $2.60 to $2.80CHARLOTTE, N.C., May 06, 2021 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY), The Dental Solutions Company, today announced its financial results for the first quarter of 2021. First quarter net sales of $1,027 million increased 17.5%, compared to $874 million in the first quarter...